DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Non-opioids Solutions for Cancer Treatment and Pain Management" report to their offering.
Marine-derived pharmaceuticals have been used as sources of providing a range of chemical diversity in drug discovery. Marine-derived pharmaceuticals are the outcome of a breakthrough application of biotechnology. They enable producing therapeutic agents that could ultimately be used by the medical community to combat life-threatening illnesses. The sudden increase in the utilization of marine-derived pharmaceutical products can be directly linked to the uptake of research activities in this space. These marine derived pharmaceutical products require a significant amount of basic and applied research, so that they can be compared in terms of efficacy and safety and quality to patented pharmaceutical products that are in the market.
Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders.
The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Key Topics Covered:
1. Innovations in Non-opioids Therapeutics
Inspired by the Sea to Discover Molecules with Antitumor Activity
Marine-based Compound Library Generation and Drug Discovery
Unparalleled Chemical Diversity in High Impact Therapeutics
2. Marine Microbial Product for Fighting Tumor Microenvironment
Non-addictive Drug Composition for Severe Pain Treatment
Novel Antibody Drug Conjugate to Limit Tumor Growth
Intrathecal Infusion for Severe Pain Minus the Bothersome Side-effects
Marine Pharmaceuticals Pipeline Analysis and Industry Interactions
For more information about this report visit http://www.researchandmarkets.com/research/tzgj9p/nonopioids